On July 15, 2026, the French National Assembly gave final approval to a landmark assisted‑dying legislation, marking a decisive step in the country's long‑standing debate over end‑of‑life care. The bill, first announced by President Emmanuel Macron more than three years ago, survived three Senate rejections; under France's bicameral system, the lower house holds the ultimate authority when the two chambers disagree.

Core Provisions of the Bill

The legislation authorises medically assisted suicide for adults who meet stringent criteria. Applicants must be at least 18 years old, either French citizens or legal residents, and diagnosed with a "serious and incurable" illness that is either in an "advanced" or "terminal" stage. The disease must cause constant physical or psychological suffering that is intolerable and unresponsive to treatment. Importantly, pure psychological distress, severe psychiatric disorders, or neurodegenerative conditions such as Alzheimer’s are excluded.

Procedural Safeguards and Constitutional Review

Patients initiate the request, which health professionals must evaluate within 15 days. After a mandatory two‑day reflection period, the patient confirms consent, and on the chosen date a doctor or nurse verifies the desire to proceed. The French national health insurance will cover all associated costs. Prime Minister Sébastien Lecornu has referred three contentious elements— the two‑day reflection period, the capacity for fully informed consent, and the role of health facilities— to the Constitutional Council for a review that could take up to a month.

Public Reaction and International Context

Advocates, such as the Association for the Right to Die With Dignity, hail the law as a means for individuals to "freely and knowingly" end unbearable suffering. Critics warn that the measure could exert subtle pressure on the elderly and disabled. Recent polls indicate a majority of French citizens support offering terminally ill patients a choice between palliative care and assisted death. Should the bill become law, France will join a small group of European nations, including the Netherlands, Belgium and Switzerland, that have legalized some form of assisted dying.

Future Implications

Beyond the immediate impact on French healthcare, the legislation may reshape global discourse on patient autonomy and end‑of‑life rights. By integrating the costs into the national health insurance system, France signals a commitment to equitable access, potentially setting a precedent for other nations grappling with similar ethical and legal dilemmas.